Reaction
Chronic Lymphocytic Leukaemia Transformation reporting signals
As of the last recalculation, Chronic Lymphocytic Leukaemia Transformation appears in 209 FAERS reports alongside 5 co-occurring drug terms. The strongest observed disproportionality signal is FLUDARABINE PHOSPHATE (PRR 202.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Fludarabine Phosphate | 58 | 202.9 | 203.2 |
| Alemtuzumab | 20 | 113.8 | 113.9 |
| Cladribine | 7 | 75.0 | 75.1 |
| Venetoclax | 32 | 60.9 | 61.0 |
| Ibrutinib | 36 | 53.4 | 53.4 |